Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Eddingpharm (Hongkong) a commercial-stage specialty pharmaceutical company focused on in-licensing and marketing oncology and other drugs in China, closed a $24 million Series B financing. Participants include OrbiMed Advisors, Domain Associates and Sequoia Capital.

Flexion Therapeutics (Woburn, MA) advances high value specialty drug candidates through clinically meaningful proof of concept and beyond, the company plans to announce deals with three major pharmas shortly, closed a $33M Series A financing. Participants include Versant Ventures, 5AM Ventures and Sofinnova Ventures. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

  

to top of page...